Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230883 | SCV003928820 | pathogenic | Monogenic diabetes | 2023-04-27 | criteria provided, single submitter | clinical testing | Variant summary: GCK c.810_814delGCTGG (p.Leu271ValfsX2) results in a premature termination codon, predicted to cause an absence of the protein due to nonsense mediated decay, a commonly known mechanism for disease. The variant was absent in 250518 control chromosomes. c.810_814delGCTGG has been reported in the literature in at-least one individual affected with Monogenic Diabetes/Maturity Onset Diabetes Of The Young 2 (example, Gloyn_2003 cited in Osbak_2009). The following publications have been ascertained in the context of this evaluation (PMID: 14517946, 19790256). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |